Artal Group S.A. Harpoon Therapeutics, Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$17.65 - $24.16 $3.53 Million - $4.83 Million	200,000 Added 25.0%	1,000,000 $20.9 Million
Q3 2020 Nov 13, 2020	SELL	$11.01 - $18.52 $1.1 Million - $1.85 Million	-100,000 Reduced 11.11%	800,000 $13.6 Million
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $3.33 Million - $7.42 Million	-300,000 Reduced 25.0%	900,000 $14.9 Million
Q1 2020 May 14, 2020	BUY	$10.74 - $16.32 $3.76 Million - $5.71 Million	350,000 Added 41.18%	1,200,000 $13.9 Million
Q4 2019 Feb 13, 2020	BUY	$12.94 - $20.58 $11 Million - $17.5 Million	850,000 New	850,000 $12.6 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.